The American College of Physicians’ recommended target A1C level of between 7% to 8% for “most” diabetes patients is “not reflective of the long-term benefits of lower A1C targets” and “could cause increased complication rates for those who may safely benefit from lower evidence-based targets,” said Dr. William Cefalu, chief scientific officer at the American Diabetes Association. The ADA also disagreed with the group’s recommendation of avoiding A1C targets in patients with a life expectancy of less than 10 years, those with chronic conditions or residing in nursing homes.